A process model of depo-provera use in Canadian women

Health Care for Women International

Volumn 24, Issue 3, 2003, Pages 193-208

  Hampton, Mary ^a   McWatters, Barb ^b  

^a UNIVERSITY OF REGINA   (Canada)

^b Planned Parenthood Regina   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE; CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CANADA; COGNITION; CONTRACEPTION; DECISION MAKING; DRUG CHOICE; DRUG USE; DRUG WITHDRAWAL; FEMALE; HEALTH EDUCATION; HUMAN; INTERVIEW; MENSTRUAL CYCLE; PATIENT COUNSELING; REPRODUCTIVE HEALTH; SOCIAL CLASS; ATTITUDE TO HEALTH; DRUG UTILIZATION; EDUCATION; MOTIVATION; NURSING METHODOLOGY RESEARCH; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; QUALITATIVE RESEARCH; QUESTIONNAIRE; SEXUAL BEHAVIOR; STATISTICS;

ADOLESCENT; ADULT; CANADA; CHOICE BEHAVIOR; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; DRUG UTILIZATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MODELS, PSYCHOLOGICAL; MOTIVATION; NURSING METHODOLOGY RESEARCH; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITATIVE RESEARCH; QUESTIONNAIRES; WOMEN;

EID: 0038660937     PISSN: 07399332     EISSN: 10964665     Source Type: Journal    
DOI: 10.1080/07399330390178477     Document Type: Article

References (34)

1. Bekinska, M. E., Rees, V. H., Nkonyane, T., & McIntyre, J. A. (1998). Compliance and use behavior, an issue in injectable as well as oral contraceptive use? A study of injectable and oral contraceptive use in Johannesburg. British Journal of Family Planning, 24, 21-23.
2. Borges, S., & Waitzkin, H. (1995). Women’s narratives in primary care medical encounters. Women and Health, 23(1), 29-56.
3. Canadian Women’s Studies. (1995). Canadian policies and practices in the area of reproduction, population, and development, 75(2-3), 159-165.
4. Fisher, W. A., Boroditsky, R., & Bridges, M. L. (1999). 1998 Canadian contraception study. Canadian Journal of Human Sexuality, 8(3), 161-216.
5. Goldman, E. L. (1999). Weight gain in Depo-Provera: A problem for teens. Family Practice News, 29(10), 42-43.
6. Grace, V. M. (1995). Problems of communication, diagnosis and treatment experienced by women using the New Zealand health services for chronic pelvic pain: A quantitative analysis. Health Care for Women International, 16, 521-535.
7. Graves, G. R. (1998). Depo-Provera for contraception. Journal SOGC, 20(Suppl.), 12-15.
8. Grimley, D. M., Riley, G. E., Bellis, J. M., & Prochaska, J. O. (1993). Assessing the stages of change and decision-making for contraceptive use for the prevention of pregnancy, sexually transmitted diseases and acquired immunodeficiency syndrome. Health Education Quarterly, 20(4), 455-470.
9. Hampton, M. R., & Frombach, I. (2000). Women’s experience of traumatic stress in cancer treatment. Health Care for Women International, 21, 67-76.
10. Harel, A., Biro, F. M., Kollar, L. M., & Rauh, J. (1996). Adolescents’ reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant. Journal of Adolescent Health, 19, 118-123.
11. Isart, F., Weber, F. T., Merrick, B. L., & Rowe, S. (1992). Use of injectable progestin (medroxyprogesterone acetate) in adolescent health care. Contraception, 46, 41-48.
12. Johnson, N. G., Roberts, M. C., & Worell, J. (Eds.). (1999). Beyond appearance: A new look at adolescent girls. Washington, D.C.: American Psychological Association.
13. Klitsch, M. (1993). Injectable hormones and regulatory controversy: An end to the long-running story? Family Planning Perspectives, 25(1), 37-40.
14. Koenigs, L. M. P., & Miller, N. H. (1995). The contraceptive use of Depo-Provera in U.S. adolescents. Journal of Adolescent Health, 16, 347-349.
15. Langille, D., Graham, J., Marshall, E., Blake, M., Chitty, C., & Doncaster-Scott, H. (2000). Developing understanding from young women’s experiences in obtaining sexual health services and education in a Nova Scotia community: Lessons for educators, physicians, and pharmacies. Nova Scotia: Maritime Centre of Excellence for Women’s Health.
16. Lei, A., Wu, S. C., Garceau, R. J., Yang, Q., Wang, W., & VanderMeulen, T. C. (1996). Effect of pretreatment counseling on discontinuation rates in Chinese women given Depo-medroxypro-gesterone Acetate for contraception. Contraception, 53, 357-361.
17. Lim, S. W., Rieder, J., Coupey, S. M., & Bijur, P. E. (1999). Depo Medroxyprogesterone Acetate use in inner-city minority adolescents: Continuation rates and characteristics of long-term users. Archives of Pediatrics and Adolescent Medicine, 153(10), 1068-1076.
18. Musham, C., Darr, E. G., & Strossner, M. L. (1995). A qualitative study of the perceptions of dissatisfied Norplant users. The Journal of Family Practice, 40(5), 465-470.
19. Nelson, A. L. (1996). Counseling issues and management of side effects using Depot-Medroxypro-gesterone Acetate contraception. The Journal of Reproductive Health, 41(5), 391-400.
20. Polaneczky, M., Guarnaccia, M., Alon, J., & Wiley, J. (1996). Early experience with the contraceptive use of Depot Medroxyprogesterone Acetate in an inner-city clinic population. Family Planning Perspectives, 28, 174-178.
21. Polaneczky, M., & LiBlanc, M. (1998). Long-term Depot Medroxyprogesterone acetate (Depo-Provera) use in inner city adolescent users. Journal of Adolescent Health, 23, 81-88.
22. Rashid, S. F. (2001). Indigenous notions of the working of the body: Conflicts and dilemmas with Norplant use in rural Bangladesh. Qualitative Health Research, 11(1), 85-102.
23. Rubin, H. J., & Rubin, I. S. (1995). Qualitative interviewing: The art of hearing data. Newbury Park, CA: Sage Publications.
24. Sangi-Haghpeykar, H., Poindexter III, A. N., Moseley, D. C., Bateman, L., & Reid, E. D. (1995). Characteristics of injectable contraceptive users in a low-income population in Texas. Family Planning Perspectives, 27, 208-225.
25. Sangi-Haghpeykar, H., Poindexter III, A. N., Bateman, L., & Ditmore, J. R. (1996). Experiences of injectable contraceptive users in an urban setting. Obstetrics and Gynecology, 88, 227-233.
26. SIECCAN. (1999). Part 10: Clinical and educational implications of the 1998 Canadian contraception study. The Canadian Journal of Human Sexuality, 8(3), 213-217.
27. Sinervo, K. R., & O’Keane, J. (1998). Depo-Provera: Experience to date. Journal SOGC, 20(Suppl.), 16-23.
28. Speroff, L. (2000). Bone and Depo-Provera. OB/GYN Clinical Alert, 76(11), 86-89.
29. Stern, P. M. (1996). Conceptualizing women’s health: Discovering the dimensions. Qualitative Health Research, 6(2), 152-162.
30. Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Grounded theory: Techniques and procedures for developing grounded theory (2nd ed.). Newbury Park, CA: Sage Publications.
31. Tanfer, K., Wierzbicki, W., & Payne, B. (2000). Why are women not using long-acting contraception? Family Planning Perspectives, 32, 176-189, 191.
32. Tolman, D. L. (1999). Female adolescent sexuality in relational context: Beyond sexual decision making. In N. G. Johnson, M. C. Roberts, & J. Worell (Eds.). Beyond appearance: A new look at adolescent girls (pp. 227-246). Washington, D.C.: American Psychological Association.
33. Tudiver, S. (1994). Population control and use of hormonal contraceptives: Third world experiences come home. Unpublished manuscript.
34. Westfall, J. M., Main, D. S., & Barnard, J. (1996). Continuation rate among injectable contraceptive users. Family Planning Perspectives, 28(6), 275-277.